Literature DB >> 18401262

Chronic allograft nephropathy: what have we learned from protocol biopsies?

Jean-Louis Bosmans1, Dirk K Ysebaert, Gert A Verpooten.   

Abstract

Chronic allograft nephropathy, characterized by interstitial fibrosis and tubular atrophy, is still a major cause of graft loss after kidney transplantation. The complex pathophysiology of chronic allograft nephropathy is still poorly understood, and could be clarified by a more systematic performance of implantation and protocol biopsies of the renal allograft. This review highlights the contribution of implantation and protocol biopsies to our current knowledge of the complex interaction of multiple processes, ultimately leading to the development of interstitial fibrosis and tubular atrophy in the transplanted kidney. In addition, the safety and the limitations of protocol biopsies are discussed, as well as potential future directions for clinical practice and clinical research.

Entities:  

Mesh:

Year:  2008        PMID: 18401262     DOI: 10.1097/TP.0b013e318169c5d0

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies.

Authors:  Aleksey Nakorchevsky; Johannes A Hewel; Sunil M Kurian; Tony S Mondala; Daniel Campbell; Steve R Head; Christopher L Marsh; John R Yates; Daniel R Salomon
Journal:  J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 10.121

Review 2.  microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

Authors:  Kirti Bhatt; Qing-Sheng Mi; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

3.  Clinical significance of contrast-enhanced ultrasound in chronic kidney disease: a pilot study.

Authors:  Seokmin Jeong; Sung Bin Park; Su-Hyun Kim; Jin Ho Hwang; Jungho Shin
Journal:  J Ultrasound       Date:  2019-10-12

Review 4.  Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profiling.

Authors:  Thangamani Muthukumar; John R Lee; Darshana M Dadhania; Ruchuang Ding; Vijay K Sharma; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Transplant Rev (Orlando)       Date:  2014-05-27       Impact factor: 3.943

5.  Significant increase in 1-year posttransplant renal arterial index predicts graft loss.

Authors:  Mélanie Terebus Loock; Jamal Bamoulid; Cécile Courivaud; Philippe Manzoni; Dominique Simula-Faivre; Jean-Marc Chalopin; Bruno Kastler; Didier Ducloux
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 8.237

6.  Assessment of renal tissue elasticity by acoustic radiation force impulse quantification with histopathological correlation: preliminary experience in chronic kidney disease.

Authors:  Liang Wang; Peng Xia; Ke Lv; Jie Han; Qing Dai; Xue-mei Li; Li-meng Chen; Yu-xin Jiang
Journal:  Eur Radiol       Date:  2014-04-18       Impact factor: 5.315

7.  Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection.

Authors:  Pamela M Kimball; Melissa A Baker; Mary B Wagner; Anne King
Journal:  Kidney Int       Date:  2011-01-26       Impact factor: 10.612

8.  The loss of renal dendritic cells and activation of host adaptive immunity are long-term effects of ischemia/reperfusion injury following syngeneic kidney transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Michael A Nalesnik; Rita M Sico; Matthew Zhang; Shinya Ueki; Mark A Ross; Donna B Stolz; Noriko Murase
Journal:  Kidney Int       Date:  2012-01-25       Impact factor: 10.612

9.  Ten years experience with belatacept-based immunosuppression after kidney transplantation.

Authors:  Gerrit Grannas; Harald Schrem; Juergen Klempnauer; Frank Lehner
Journal:  J Clin Med Res       Date:  2014-02-06

10.  Usefulness of Contrast-enhanced Ultrasound in the Evaluation of Chronic Kidney Disease.

Authors:  Byoung Hee Han; Sung Bin Park
Journal:  Curr Med Imaging       Date:  2021
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.